Related Experiment Video
Updated: Mar 21, 2026
Microinjection of mRNA and Morpholino Antisense Oligonucleotides in Zebrafish Embryos.
Published on: May 7, 2009
Approaches to Inactivate Genes in Zebrafish
John M Parant1, Jing-Ruey Joanna Yeh2,3
1Department of Pharmacology and Toxicology, UAB Comprehensive Cancer Center, University of Alabama at Birmingham School of Medicine, Birmingham, AL, 35294, USA. jparant@uab.edu.
Abstract:
Animal models of tumor initiation and tumor progression are essential components toward understanding cancer and designing/validating future therapies. Zebrafish is a powerful model for studying tumorigenesis and has been successfully exploited in drug discovery. According to the zebrafish reference genome, 82 % of disease-associated genes in the Online Mendelian Inheritance in Man (OMIM) database have clear zebrafish orthologues. Using a variety of large-scale random mutagenesis methods developed to date, zebrafish can provide a unique opportunity to identify gene mutations that may be associated with cancer predisposition. On the other hand, newer technologies enabling targeted mutagenesis can facilitate reverse cancer genetic studies and open the door for complex genetic analysis of tumorigenesis. In this chapter, we will describe the various technologies for conducting genome editing in zebrafish with special emphasis on the approaches to inactivate genes.
Insights
Zebrafish models offer powerful tools for cancer research, enabling the identification of cancer predisposition genes and facilitating the study of tumor development. Genome editing technologies in zebrafish are crucial for advancing cancer genetics and drug discovery.
Area of Science:
- Comparative genomics
- Cancer biology
- Developmental biology
Background:
- Animal models are crucial for understanding cancer initiation and progression.
- Zebrafish are a well-established model organism for cancer research and drug discovery.
- A high percentage of human disease genes have zebrafish orthologs, supporting their use in genetic studies.
Purpose of the Study:
- To review genome editing technologies in zebrafish for cancer research.
- To highlight the application of zebrafish in identifying cancer predisposition genes.
- To discuss methods for gene inactivation in zebrafish for tumorigenesis studies.
Main Methods:
- Utilizing large-scale random mutagenesis to identify cancer-associated gene mutations.
- Employing targeted mutagenesis and newer genome editing technologies for reverse genetics.
- Focusing on gene inactivation approaches within zebrafish.
Main Results:
- Zebrafish possess orthologs for 82% of OMIM disease genes.
- Random mutagenesis screens can identify novel cancer predisposition genes.
- Targeted mutagenesis enables complex genetic analyses of tumorigenesis.
Conclusions:
- Zebrafish are a versatile model for cancer research due to genetic homology and advanced genome editing tools.
- Genome editing, particularly gene inactivation, is key to understanding cancer genetics in zebrafish.
- This approach aids in the development and validation of novel cancer therapies.
